Investors & Media : on Data Provided by Refinitiv. Minimum 15 minutes delayed. Intra 3 mo. 6 mo. 1 yr. News Releases Intercept to Announce Second Quarter 2020 Financial Results on August 10, 2020 Aug 03, 2020 Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH Jun 29, 2020 Intercept Provides Regulatory Update May 22, 2020 Intercept Pharmaceuticals Reports First Quarter 2020 Financial Results, and Provides Business Update May 11, 2020 View all press releases > Recent Events and Presentations Q2 2020 Intercept Pharmaceuticals Earnings Call Aug 10, 2020 at 8:30 AM EDT Conference Call Jun 29, 2020 at 8:30 AM EDT Bank of America Merrill Lynch Virtual Global Healthcare Conference May 13, 2020 at 2:20 PM EDT Q1 2020 Intercept Pharmaceuticals Earnings Call May 11, 2020 at 8:30 AM EDT View all events & presentations >
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid for the Treatment of Fibrosis Due to NASH Jun 29, 2020
Intercept Pharmaceuticals Reports First Quarter 2020 Financial Results, and Provides Business Update May 11, 2020
